David Altshuler, EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,111 shares at $480.00 ($533K) on 2025-02-20, disclosed to the SEC on 2025-02-24.
Scheduled sale ($533k) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $611K | — | Filing → |